Redeye initiating coverage of Amniotics
October 12, 2021
Redeye is initiating coverage of Amniotics and today sent out their first analysis:
Redeye are specialists in innovative and fast-growing Nordic companies in Life Science and Technology. The company has a market-leading position and offers services in stock analysis, Corporate Finance and Corporate Broking. The analyzes are based on a value-based investment philosophy and a unique rating model. Redeye was founded in 1999, is an authorized securities company and is under the supervision of Finansinspektionen.